Literature DB >> 2026442

Secondary immunoglobulin responses of BALB/c mice previously stimulated with goat anti-mouse IgD.

B R Champion1, S Buckham, K Page, H Obray, E D Zanders.   

Abstract

Intravenous injection of goat antibodies to mouse IgD (GAMD) into BALB/c mice has been shown to induce vigorous T-cell dependent immunoglobulin responses, particularly of the IgG1 and IgE isotypes. We have confirmed these findings and show that IgA responses are also triggered in this model. Since the study of IgE regulation in allergic individuals is concerned with secondary and subsequent T- and B-cell responses, we boosted GAMD-primed mice with goat antibodies to IgE or IgA in an attempt to specifically retrigger IgE- and IgA-bearing memory B cells. However, we found that secondary IgG1, IgE and IgA production could be elicited equally well by either antibody preparation or by normal goat IgG (GIg). As with the primary response, GIg primed and boosted mice produced very low or undetectable IgG1, IgE and IgA responses. These data suggest that GAMD is very efficient at priming T cells specific for GIg epitopes and that once primed they can be readily re-triggered by GIg. Spleen cells taken 7 days after boosting GAMD-primed mice were found to spontaneously produce much higher levels of interleukin-6 (IL-6) in culture than cells from unboosted or GIg primed and boosted mice. In contrast to primary responses, where IgE levels return to background (less than 40 ng/ml) very quickly, circulating IgE levels in boosted mice initially declined before reaching a plateau level (approximately 1 microgram/ml) which was maintained for at least 148 days. IgG1 and IgA levels continued to fall over this same time period. Mice which had been primed (but not boosted) 10 months earlier were all found to have detectable IgE in their blood, despite the fact that following priming IgE becomes undetectable within 2-3 weeks. Since only a part of the IgE response was directed towards the antigen (GIg), these observations suggest the possibility that B cells initially primed to make IgE can be non-specifically retriggered in vivo.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2026442      PMCID: PMC1384392     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

Review 1.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo.

Authors:  S P Cobbold; A Jayasuriya; A Nash; T D Prospero; H Waldmann
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

3.  Reaginic antibody formation in the mouse. XI. Participation of long-lived antibody-forming cells in persistent antibody formation.

Authors:  H Okudaira; K Ishizaka
Journal:  Cell Immunol       Date:  1981-02       Impact factor: 4.868

4.  Polyclonal activation of the murine immune system by an antibody to IgD. I. Increase in cell size and DNA synthesis.

Authors:  F D Finkelman; I Scher; J J Mond; J T Kung; E S Metcalf
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

5.  Polyclonal activation of the murine immune system by an antibody to IgD. II. Generation of polyclonal antibody production and cells with surface IgG.

Authors:  F D Finkelman; I Scher; J J Mond; S Kessler; J T Kung; E S Metcalf
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

6.  Cytophilic antibody. I. Nature of the macrophage receptor.

Authors:  M J Davey; G L Asherson
Journal:  Immunology       Date:  1967-01       Impact factor: 7.397

7.  Clearance of IgE from serum of normal and hybridoma-bearing mice.

Authors:  S Haba; Z Ovary; A Nisonoff
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

8.  B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells.

Authors:  R L Coffman; J Ohara; M W Bond; J Carty; A Zlotnik; W E Paul
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

9.  Bystander help in primary immune responses in vivo.

Authors:  P E Jensen; J A Kapp
Journal:  J Exp Med       Date:  1986-09-01       Impact factor: 14.307

10.  Development of allergy in children. I. Association with virus infections.

Authors:  O L Frick; D F German; J Mills
Journal:  J Allergy Clin Immunol       Date:  1979-04       Impact factor: 10.793

View more
  2 in total

1.  IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb cross-linking.

Authors:  Richard T Strait; Suzanne C Morris; Fred D Finkelman
Journal:  J Clin Invest       Date:  2006-02-23       Impact factor: 14.808

2.  Anti-FcγRIIB mAb suppresses murine IgG-dependent anaphylaxis by Fc domain targeting of FcγRIII.

Authors:  Corey D Clay; Richard T Strait; Ashley Mahler; Marat V Khodoun; Fred D Finkelman
Journal:  J Allergy Clin Immunol       Date:  2017-06-15       Impact factor: 10.793

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.